A morpholino oligomer therapy regime that restores mitochondrial function and prevents mdx cardiomyopathy. Viola HM, Johnstone VPA, Adams AM, Fletcher S, Hool LC. JACC Basic Transl Sci. 2018 Jun; 3(3):391-402.